Browsing by Author Segelov, Eva

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 28  next >
Issue DateTitleAuthor(s)Citation
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2013Breast cancer: Screening, prevention, support and other aspectsDhillon, Haryana; Chua, Boon; Connolly, Kate; Mann, Bruce; Segelov, Eva; Central Clinical School: MedicineBreast cancer: Screening, prevention, support and other aspects, Medicine Today, vol.14, 8, 2013,pp 29-36
2014Cost-Effectiveness of Aspirin Adjuvant Therapy in Early Stage Colorectal Cancer in Older PatientsSegelov, Eva; Ali, Raghib; Chan, Mun-Ling; Chia, John Whay-Kuang; Deng, Yan Hong; Ho, Gwo Fuang; Jian, Xiao; Mehta, Shaesta; Soon, Swee Sung; Tan, Chuen-Seng; Toh, Han-Chong; Wee, Hwee-Lin; School of Public Health: NH&MRC Clinical Trials CentreCost-Effectiveness of Aspirin Adjuvant Therapy in Early Stage Colorectal Cancer in Older Patients, PloS One, vol.9, 9, 2014,pp 1-14
2014Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013Pavlakis, Nick; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos; Price, Timothy; Punt, Cornelis JA; Segelov, Eva; Shapiro, J; Tebbutt, Niall; Northern Clinical School: MedicineCurrent opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013, Expert Review of Anticancer Therapy, vol.14, 12, 2014,pp 1477-1493
2013Current opinion on optimal treatment for colorectal cancerPavlakis, Nick; Ackland, Stephen P.; Burge, Matthew; Cunningham, David; Haller, Daniel; Karapetis, Christos; Price, Timothy; Segelov, Eva; Shapiro, Jeremy; Sobrero, Alberto; Tebbutt, Niall C; Northern Clinical School: MedicineCurrent opinion on optimal treatment for colorectal cancer, Expert Review of Anticancer Therapy, vol.13, 5, 2013,pp 597-611
2015Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literatureChan, David; Pavlakis, Nick; Karapetis, Christos; Price, Timothy; Segelov, Eva; Shapiro, J; Tebbutt, Niall; Northern Clinical School: Medicine; Northern Clinical School: MedicineDoes the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literature, PloS One, vol.10, 8, 2015,pp 1-17
2016ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumoursGebski, Val; Khasraw, Mustafa; Pavlakis, Nick; Thavaneswaran, Subotheni; Wilson, Kate; Chantrill, Lorraine A; Day, Fiona; Desai, Jayesh; Elez, Elena; et al, Various; Jefford, Michael; Nott, Louise M; Segelov, Eva; Underhill, Craig; Waring, Paul; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours, BMC Cancer, vol.16, 1, 2016,pp 1-8
2012Identifying and prioritising gaps in colorectal cancer trials research in AustraliaBarratt, Alexandra; Dear, Rachel; Simes, Robert John; Tattersall, Martin; Crossing, Sally; Evans, Alison; Holliday, Cath; Hruby, George; Kent, Dan; Newsom, John; Segelov, Eva; School of Public Health: Public Health; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: MedicineIdentifying and prioritising gaps in colorectal cancer trials research in Australia, Medical Journal of Australia, vol.197, 9, 2012,pp 507-511
2017Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor CollaborationPavlakis, Nick; Chan, David; Jackson, Christopher; Kennecke, Hagen F.; Law, Calvin; Lawrence, Ben; Segelov, Eva; Singh, Simron; Northern Clinical School: MedicineIdentifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration, Journal of Global Oncology, vol.3, 4, 2017,pp 380-388
2013Improving the impact of didactic resident training with online spaced educationNicholson, James; Shaw, Timothy; Baker, Caroline; Gyorki, David; Mann, Bruce; Pitcher, Meron; Segelov, Eva; Skandarajah, Anita; Other or Unknown; Deans Unit: (CIPHER)Improving the impact of didactic resident training with online spaced education, ANZ Journal of Surgery, vol.83, 6, 2013,pp 477-480
2016JRK is a positive regulator of Beta-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancerParker, Benjamin Leo; Al-Sohaily, Sam; Benthani, F; Carey, Louise; Cowley, Mark; Currey, N; Giry-Laterriere, M; Kohonen-Corish, Maija R.J.; Morgan, A; Ng, I; Pangon, Laurent; Rooman, Ilse; Segelov, Eva; St Heaps, Luke; Tran, P; Wright, D C; Molecular BioscienceJRK is a positive regulator of Beta-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer, Oncogene, vol.35, 22, 2016,pp 2834-2841
2016JRK is a positive regulator of Beta-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancerParker, Benjamin Leo; Al-Sohaily, Sam; Benthani, F; Carey, Louise; Cowley, Mark; Currey, N; Giry-Laterriere, M; Kohonen-Corish, Maija R.J.; Morgan, A; Ng, I; Pangon, Laurent; Rooman, Ilse; Segelov, Eva; St Heaps, Luke; Tran, P; Wright, D C; Molecular BioscienceJRK is a positive regulator of Beta-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer, Oncogene, vol.35, 22, 2016,pp 2834-2841
2012Management of advanced gastric cancerPavlakis, Nick; Price, Timothy; Segelov, Eva; Tebbutt, Niall; Kang, Yoon-Koo; Karapetis, Christos; Shah, Manish; Shapiro, Jeremy; Van Cutsem, E; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreManagement of advanced gastric cancer, Expert Review of Gastroenterology and Hepatology, vol.6, 2, 2012,pp 199-209